October 24, 2016 / 12:36 PM / 3 years ago

BRIEF-Advaxis announces GOG-0265 12-month overall survival rate of 37.5 pct in Stage 2

Oct 24 (Reuters) - Advaxis Inc

* Advaxis announces gog-0265 12-month overall survival rate of 37.5% in stage 2

* Advaxis plans to pursue registrational opportunities in europe in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below